{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:08:52Z","timestamp":1789470532025,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP24KJ1780"],"award-info":[{"award-number":["JP24KJ1780"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP25K12836"],"award-info":[{"award-number":["JP25K12836"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00417-026-07130-6","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T06:54:51Z","timestamp":1771224891000},"page":"2821-2829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Wide-field choroidal thickness changes after loading-phase anti-VEGF therapy in treatment-na\u00efve neovascular AMD"],"prefix":"10.1007","volume":"264","author":[{"given":"Yosuke","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Notomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Shiose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodai","family":"Yuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"7130_CR1","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"351","author":"ES Gragoudas","year":"2004","unstructured":"Gragoudas ES, Adamis AP, Cunningham ET Jr., Feinsod M, Guyer DR (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805\u20132816. https:\/\/doi.org\/10.1056\/NEJMoa042760","journal-title":"N Engl J Med"},{"key":"7130_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419\u20131431. https:\/\/doi.org\/10.1056\/NEJMoa054481","journal-title":"N Engl J Med"},{"key":"7130_CR3","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","volume":"364","author":"DF Martin","year":"2011","unstructured":"Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897\u20131908. https:\/\/doi.org\/10.1056\/NEJMoa1102673","journal-title":"N Engl J Med"},{"key":"7130_CR4","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U (2012) Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119:2537\u20132548. https:\/\/doi.org\/10.1016\/j.ophtha.2012.09.006","journal-title":"Ophthalmology"},{"key":"7130_CR5","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","volume":"123","author":"MG Maguire","year":"2016","unstructured":"Maguire MG, Martin DF, Ying GS, Jaffe GJ, Daniel E, Grunwald JE, Toth CA, Ferris FL 3rd, Fine SL (2016) Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology 123:1751\u20131761. https:\/\/doi.org\/10.1016\/j.ophtha.2016.03.045","journal-title":"Ophthalmology"},{"key":"7130_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10384-025-01178-3","volume":"69","author":"Y Fukuda","year":"2025","unstructured":"Fukuda Y, Shiose S, Notomi S, Maehara Y, Mori K, Hashimoto S, Kano K, Ishikawa K, Sonoda KH (2025) Two-year treatment outcomes after anti-vascular endothelial growth factor therapy in age-related macular degeneration with type 2 macular neovascularization in Japanese patients. Jpn J Ophthalmol 69:371\u2013377. https:\/\/doi.org\/10.1007\/s10384-025-01178-3","journal-title":"Jpn J Ophthalmol"},{"key":"7130_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","volume":"26","author":"N Ferrara","year":"2006","unstructured":"Ferrara N, Damico L, Shams N, Lowman H, Kim R (2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26:859\u2013870. https:\/\/doi.org\/10.1097\/01.iae.0000242842.14624.e7","journal-title":"Retina"},{"key":"7130_CR8","doi-asserted-by":"publisher","first-page":"H1054","DOI":"10.1152\/ajpheart.1998.274.3.H1054","volume":"274","author":"JD Hood","year":"1998","unstructured":"Hood JD, Meininger CJ, Ziche M, Granger HJ (1998) VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 274:H1054-1058. https:\/\/doi.org\/10.1152\/ajpheart.1998.274.3.H1054","journal-title":"Am J Physiol"},{"key":"7130_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","volume":"146","author":"RF Spaide","year":"2008","unstructured":"Spaide RF, Koizumi H, Pozzoni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146:496\u2013500. https:\/\/doi.org\/10.1016\/j.ajo.2008.05.032","journal-title":"Am J Ophthalmol"},{"key":"7130_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ophtha.2015.10.039","volume":"123","author":"H Koizumi","year":"2016","unstructured":"Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T (2016) Subfoveal choroidal thickness during Aflibercept therapy for neovascular age-related macular degeneration: twelve-month results. Ophthalmology 123:617\u2013624. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.039","journal-title":"Ophthalmology"},{"key":"7130_CR11","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1007\/s12325-022-02129-x","volume":"39","author":"AM Minnella","year":"2022","unstructured":"Minnella AM, Centini C, Gambini G, Savastano MC, Pagliei V, Falsini B, Rizzo S, Ciasca G, Maceroni M (2022) Choroidal thickness changes after intravitreal Aflibercept injections in treatment-na\u00efve neovascular AMD. Adv Ther 39:3248\u20133261. https:\/\/doi.org\/10.1007\/s12325-022-02129-x","journal-title":"Adv Ther"},{"key":"7130_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165364","author":"Y Fukuda","year":"2023","unstructured":"Fukuda Y, Notomi S, Shiose S, Kano K, Hashimoto S, Fujiwara K, Akiyama M, Ishikawa K, Hisatomi T, Sonoda KH (2023) Differences in central and peripheral choroidal thickness among the subtypes of age-related macular degeneration in an Asian population. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12165364","journal-title":"J Clin Med"},{"key":"7130_CR13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.oret.2022.04.011","volume":"6","author":"M Ishikura","year":"2022","unstructured":"Ishikura M, Muraoka Y, Nishigori N, Takahashi A, Miyake M, Ueda-Arakawa N, Miyata M, Ooto S, Tsujikawa A (2022) Widefield choroidal thickness of eyes with central serous chorioretinopathy examined by swept-source OCT. Ophthalmol Retina 6:949\u2013956. https:\/\/doi.org\/10.1016\/j.oret.2022.04.011","journal-title":"Ophthalmol Retina"},{"key":"7130_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00417-022-05905-1","volume":"261","author":"R Funatsu","year":"2023","unstructured":"Funatsu R, Sonoda S, Terasaki H, Shiihara H, Mihara N, Horie J, Sakamoto T (2023) Choroidal morphologic features in central serous chorioretinopathy using ultra-widefield optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 261:971\u2013979. https:\/\/doi.org\/10.1007\/s00417-022-05905-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7130_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13061608","author":"Y Fukuda","year":"2024","unstructured":"Fukuda Y, Notomi S, Shiose S, Maehara Y, Kiyohara K, Hashimoto S, Kano K, Ishikawa K, Hisatomi T, Sonoda KH (2024) Wide-field choroidal thickness analysis after half-fluence photodynamic therapy combined with intravitreal aflibercept injection in pachychoroid neovasculopathy. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13061608","journal-title":"J Clin Med"},{"key":"7130_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47325-z","volume":"13","author":"H Matsumoto","year":"2023","unstructured":"Matsumoto H, Hoshino J, Nakamura K, Kishi S, Akiyama H (2023) Attenuation of irradiated choroid and its regional vortex veins in central serous chorioretinopathy after photodynamic therapy. Sci Rep 13:19903. https:\/\/doi.org\/10.1038\/s41598-023-47325-z","journal-title":"Sci Rep"},{"key":"7130_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282057","volume":"18","author":"R Funatsu","year":"2023","unstructured":"Funatsu R, Sonoda S, Terasaki H, Shiihara H, Mihara N, Horie J, Sakamoto T (2023) Effect of photodynamic therapy on choroid of the medial area from optic disc in patients with central serous chorioretinopathy. PLoS One 18:e0282057. https:\/\/doi.org\/10.1371\/journal.pone.0282057","journal-title":"PLoS One"},{"key":"7130_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/iae.0000000000004651","author":"S Wakugawa","year":"2025","unstructured":"Wakugawa S, Imanaga N, Terao N, Kuroshima C, Miyara Y, Maehira M, Koizumi H (2025) Changes in widefield choroidal thickness after anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Retina DOI. https:\/\/doi.org\/10.1097\/iae.0000000000004651","journal-title":"Retina DOI"},{"key":"7130_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10384-021-00869-x","volume":"65","author":"K Yamashiro","year":"2021","unstructured":"Yamashiro K, Oishi A, Hata M, Takahashi A, Tsujikawa A (2021) Visual acuity outcomes of anti-VEGF treatment for neovascular age-related macular degeneration in clinical trials. Jpn J Ophthalmol 65:741\u2013760. https:\/\/doi.org\/10.1007\/s10384-021-00869-x","journal-title":"Jpn J Ophthalmol"},{"key":"7130_CR20","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1007\/s00417-024-06582-y","volume":"262","author":"Y Fukuda","year":"2024","unstructured":"Fukuda Y, Notomi S, Shiose S, Maehara Y, Kiyohara K, Fujiwara K, Hashimoto S, Kano K, Ishikawa K, Hisatomi T, Sonoda KH (2024) Three-month outcomes of treatment with faricimab or aflibercept for neovascular age-related macular degeneration: a propensity score matching study in a Japanese population. Graefes Arch Clin Exp Ophthalmol 262:3971\u20133978. https:\/\/doi.org\/10.1007\/s00417-024-06582-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7130_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2147\/opth.S448507","volume":"18","author":"A Tanaka","year":"2024","unstructured":"Tanaka A, Hata M, Tsuchikawa M, Ueda-Arakawa NU, Tamura H, Miyata M, Takahashi A, Kido A, Muraoka Y, Miyake M, Ooto S, Tsujikawa A (2024) Short-term outcomes of 3 monthly intravitreal faricimab on different subtypes of neovascular age-related macular degeneration. Clin Ophthalmol 18:507\u2013516. https:\/\/doi.org\/10.2147\/opth.S448507","journal-title":"Clin Ophthalmol"},{"key":"7130_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46:399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786","journal-title":"Multivar Behav Res"},{"key":"7130_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212055","volume":"14","author":"K Azuma","year":"2019","unstructured":"Azuma K, Tan X, Asano S, Shimizu K, Ogawa A, Inoue T, Murata H, Asaoka R, Obata R (2019) The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy. PLoS One 14:e0212055. https:\/\/doi.org\/10.1371\/journal.pone.0212055","journal-title":"PLoS One"},{"key":"7130_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00417-020-04957-5","volume":"259","author":"M Pellegrini","year":"2021","unstructured":"Pellegrini M, Bernabei F, Mercanti A, Sebastiani S, Peiretti E, Iovino C, Casini G, Loiudice P, Scorcia V, Giannaccare G (2021) Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 259:911\u2013918. https:\/\/doi.org\/10.1007\/s00417-020-04957-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7130_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1167\/iovs.18-24522","volume":"60","author":"T Hikichi","year":"2019","unstructured":"Hikichi T, Agarie M (2019) Reduced vessel density of the choriocapillaris during anti-Vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 60:1088\u20131095. https:\/\/doi.org\/10.1167\/iovs.18-24522","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7130_CR26","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.11.15","volume":"65","author":"T Todoroki","year":"2024","unstructured":"Todoroki T, Takeuchi J, Ota H, Nakano Y, Sajiki AF, Nakamura K, Kaneko H, Nishiguchi KM (2024) Aqueous humor cytokine analysis in age-related macular degeneration after switching from aflibercept to faricimab. Invest Ophthalmol Vis Sci 65:15. https:\/\/doi.org\/10.1167\/iovs.65.11.15","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7130_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-025-01264-6","author":"Y Maehara","year":"2025","unstructured":"Maehara Y, Notomi S, Shiose S, Fukuda Y, Kiyohara K, Kano K, Ishikawa K, Hisatomi T, Sonoda KH (2025) Switching to faricimab alleviates persistent subretinal fluid and pigment epithelial detachment in neovascular age-related macular degeneration. Jpn J Ophthalmol. https:\/\/doi.org\/10.1007\/s10384-025-01264-6","journal-title":"Jpn J Ophthalmol"},{"key":"7130_CR28","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/bjophthalmol-2018-312625","volume":"103","author":"JB Kumar","year":"2019","unstructured":"Kumar JB, Wai KM, Ehlers JP, Singh RP, Rachitskaya AV (2019) Subfoveal choroidal thickness as a prognostic factor in exudative age-related macular degeneration. Br J Ophthalmol 103:918\u2013921. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312625","journal-title":"Br J Ophthalmol"},{"key":"7130_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00417-017-3888-2","volume":"256","author":"W Fan","year":"2018","unstructured":"Fan W, Abdelfattah NS, Uji A, Lei J, Ip M, Sadda SR, Wykoff CC (2018) Subfoveal choroidal thickness predicts macular atrophy in age-related macular degeneration: results from the TREX-AMD trial. Graefes Arch Clin Exp Ophthalmol 256:511\u2013518. https:\/\/doi.org\/10.1007\/s00417-017-3888-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7130_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154614","author":"K Yamashiro","year":"2022","unstructured":"Yamashiro K, Yanagi Y, Koizumi H, Matsumoto H, Cheung CMG, Gomi F, Iida T, Tsujikawa A (2022) Relationship between pachychoroid and polypoidal choroidal vasculopathy. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11154614","journal-title":"J Clin Med"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07130-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07130-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07130-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:53:31Z","timestamp":1789455211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07130-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7130"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07130-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7890508\/v1","asserted-by":"object"}]},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board at Kyushu University, Fukuoka, Japan (REB #26\u2013131) and adhered to the tenets of the Declaration of Helsinki. The requirement for obtaining informed consent was waived, and all data were anonymized prior to data analysis.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Funding.","order":2,"name":"Ethics","label":"Compliance with ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}